A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients.

Abstract:

BACKGROUND:Patients with multiple myeloma (MM) have increased bone marrow angiogenesis, a low plasma cell labeling index, and multidrug resistance (the primary cause of chemotherapy failure). MM patients receiving the vincristine, doxorubicin, and dexamethasone (VAD) regimen develop resistance and cardiac and steroid toxicity. Pegylated liposomal doxorubicin (Doxil/CAELYX) could potentially extend the duration of malignant plasma cell exposure to therapeutic levels of doxorubicin. This Phase II study evaluates combination pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone in MM patients. METHODS:Thirty-three newly diagnosed patients with MM received intravenous pegylated liposomal doxorubicin (40 mg/m(2)), vincristine (2.0 mg, Day 1), and oral or intravenous dexamethasone (40 mg per day for 4 days) every 4 weeks for six or more cycles and/or for two cycles after the best response. RESULTS:The overall response rate was 88%: 4 (12%) patients achieved a complete response, 18 (55%) a major response, and 7 (21%) a minor response. Three patients (9%) had stable and one (3%) had progressive disease. The median time to progression was 23.1 months, with 2-year and 3-year progression-free survival rates of 42% and 23%, respectively. The patient survival rate at 3 years was 67%. No patients discontinued treatment due to adverse events. Myelosuppression was manageable. The most common toxicities were Grade 3 palmar-plantar erythrodysesthesia, mucositis, and neutropenia. Only one patient experienced cardiotoxicity. CONCLUSIONS:Substituting pegylated liposomal doxorubicin for doxorubicin in the VAD regimen and reducing the dose of dexamethasone in patients with MM improve the safety profile and convenience of the treatment regimen without compromising efficacy.

journal_name

Cancer

journal_title

Cancer

authors

Hussein MA,Wood L,Hsi E,Srkalovic G,Karam M,Elson P,Bukowski RM

doi

10.1002/cncr.10946

subject

Has Abstract

pub_date

2002-11-15 00:00:00

pages

2160-8

issue

10

eissn

0008-543X

issn

1097-0142

journal_volume

95

pub_type

临床试验,杂志文章

相关文献

CANCER文献大全
  • Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee.

    abstract:BACKGROUND:As increasing numbers of young patients with cancer survive, interest in the late effects of therapy is rising. METHODS:The sequelae of treatment were reviewed after a minimum of 5 years of observation in 109 surviving patients with sarcoma of the bladder or prostate who were enrolled in the Intergroup Rhab...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930401)71:7<2387::aid-cncr2820

    authors: Raney B Jr,Heyn R,Hays DM,Tefft M,Newton WA Jr,Wharam M,Vassilopoulou-Sellin R,Maurer HM

    更新日期:1993-04-01 00:00:00

  • Recovery from aspermia induced by low-dose radiation in seminoma patients.

    abstract::Gonadal dosimetry and spermatogenic activity was monitored in patients given radiation therapy (RT) after unilateral orchiectomy for seminoma. The RT given was, with minor variations, 3200 rad in 16 fractions in four weeks to the para-aortic and ipsilateral pelvic inguinal lymphatics in order to include the orchiectom...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820715)50:2<337::aid-cncr28205

    authors: Hahn EW,Feingold SM,Simpson L,Batata M

    更新日期:1982-07-15 00:00:00

  • Lymph node metastases with PAS-positive tumor cells and massive epithelioid granulomatous reaction as diagnostic clue to occult seminoma.

    abstract::Two cases of occult seminoma were observed which showed left-sided lymph node metastases without clinically demonstrable testicular tumors. The peculiar histology of the lymph node metastases, namely PAS-positive tumor cells with clear cytoplasm together with a granulomatous stromal reaction, was highly suggestive of ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197907)44:1<245::aid-cncr2820440

    authors: Richter HJ,Leder LD

    更新日期:1979-07-01 00:00:00

  • Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.

    abstract:BACKGROUND:Bortezomib has preclinical and clinical in B-cell lymphomas, both alone and in combination with other agents. A phase 1 evaluation was conducted of bortezomib with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with untreated diffuse large B-cell lymphoma (DLBC...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25509

    authors: Furman RR,Martin P,Ruan J,Cheung YK,Vose JM,LaCasce AS,Elstrom R,Coleman M,Leonard JP

    更新日期:2010-12-01 00:00:00

  • Prognosis for primary retroperitoneal sarcoma survivors: a conditional survival analysis.

    abstract:BACKGROUND:The AJCC staging system and post-operative nomograms use patient and tumor characteristics to provide prognostic estimates after resection of retroperitoneal sarcoma (RPS). While these variables help to predict survival at the time of diagnosis and resection, the applicability of these prognostic factors to ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26665

    authors: Abbott AM,Habermann EB,Parsons HM,Tuttle T,Al-Refaie W

    更新日期:2012-07-01 00:00:00

  • A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.

    abstract::Five hundred and sixty-six patients with either Stage III or IV Hodgkin's disease were prospectively randomized to test whether CCNU and/or vinblastine are more effective than mechlorethamine and/or vincristine with procarbazine and prednisone. The combination of CCNU, vinblastine, procarbazine, and prednisone (CVPP) ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19800815)46:4<654::aid-cncr28204

    authors: Cooper MR,Pajak TF,Nissen NI,Stutzman L,Brunner K,Cuttner J,Falkson G,Grunwald H,Bank A,Leone L,Seligman BR,Silver RT,Weiss RB,Haurani F,Blom J,Spurr CL,Glidewell OJ,Gottlieb AJ,Holland JF

    更新日期:1980-08-15 00:00:00

  • Surviving cancer.

    abstract::Research trends on quality of life outcomes for cancer survivors are discussed. Epidemiologic data indicate that female cancer survivors, coming primarily from patient groups with gynecologic, breast, and colorectal cancers, will outnumber male survivors 3 to 1. Male survivors will come from the ranks of patient group...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19940815)74:4+<1484::aid-cncr282

    authors: Andersen BL

    更新日期:1994-08-15 00:00:00

  • Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma.

    abstract:BACKGROUND:The results of a Phase II study of concurrent chemotherapy and accelerated fractionation radiation therapy followed by surgical resection for patients with both adenocarcinoma and squamous cell carcinoma of the esophagus are presented. Pretreatment and postinduction staging were correlated with pathologic fi...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Adelstein DJ,Rice TW,Becker M,Larto MA,Kirby TJ,Koka A,Tefft M,Zuccaro G

    更新日期:1997-09-15 00:00:00

  • Imaging at diagnosis impacts cancer-specific survival among patients with cancer of the oropharynx.

    abstract:BACKGROUND:The optimal imaging for the staging of oropharyngeal cancer is not well defined. METHODS:The linked Surveillance, Epidemiology, and End Results (SEER)-Medicare database for 2006 through 2011 was used to compare patient characteristics and hospital region by the initial imaging modality used for patients wit...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32148

    authors: Morgan RL,Eguchi MM,Mueller AC,Daugherty SL,Amini A,Karam SD

    更新日期:2019-08-15 00:00:00

  • Long-term survival in adolescent and adult acute lymphoblastic leukemia.

    abstract::Among 164 patients with acute lymphoblastic leukemia (ALL) (age greater than 11 years) induced into complete remission at four hospitals in Italy and The Netherlands between 1971-1977, 49 survived for more than three years in continuous complete remission. Features at diagnosis of the 49 long-term survivors were compa...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830701)52:1<30::aid-cncr282052

    authors: Amadori S,Meloni G,Baccarani M,Haanen C,Willemze R,Corbelli G,Drenthe-Schonk A,Cardozo PL,Tura S,Mandelli F

    更新日期:1983-07-01 00:00:00

  • Radiation therapy of malignant melanomas: an evaluation of clinically used fractionation schemes.

    abstract::To assess the importance of radiation dose fraction size in the treatment of malignant melanomas, the records of 48 patients (83 sites) treated at Tufts-New England Medical Center from 1971 to 1979 have been retrospectively reviewed. During this period, the dose fractionation schemes evolved from standard fraction siz...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810315)47:6<1262::aid-cncr2820

    authors: Strauss A,Dritschilo A,Nathanson L,Piro AJ

    更新日期:1981-03-15 00:00:00

  • Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes.

    abstract:BACKGROUND:The high mortality associated with ovarian carcinoma is largely a reflection of the inability to diagnose the disease at an early stage; the identification of a histologic lesion or molecular marker associated early stages of transformation would represent an important advance in understanding the natural hi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20000715)89:2<383::aid-cncr25>3.

    authors: Barakat RR,Federici MG,Saigo PE,Robson ME,Offit K,Boyd J

    更新日期:2000-07-15 00:00:00

  • Validation of a multidimensional evaluation scale for use in elderly cancer patients.

    abstract:BACKGROUND:Although aging is one of the most important risk factors for cancer, elderly patients tend to be excluded from cancer clinical trials, only on the basis of chronologic age. Performance Status (PS) has been used widely to select adult patients for entry into clinical trials, but it does not include a comprehe...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(SICI)1097-0142(19960115)77:2<395::AID-CNC

    authors: Monfardini S,Ferrucci L,Fratino L,del Lungo I,Serraino D,Zagonel V

    更新日期:1996-01-15 00:00:00

  • Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma.

    abstract:BACKGROUND:: Histologic parameters of melanoma deposits in sentinel lymph nodes (SLNs) have been shown to be predictive of clinical outcome and the presence or absence of tumor in non-SLNs, but assessment of these parameters is prone to interobserver variation. METHODS:: Histologic sections of 44 SLNs containing metas...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24298

    authors: Murali R,Cochran AJ,Cook MG,Hillman JD,Karim RZ,Moncrieff M,Starz H,Thompson JF,Scolyer RA

    更新日期:2009-11-01 00:00:00

  • MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy.

    abstract:BACKGROUND:The authors are interested in identifying molecular markers that can aid in the diagnosis of adrenocortical carcinoma (ACC). The aim of this study was to identify microRNAs (miRNAs or miRs) that are differentially expressed in malignant adrenocortical tumors as compared with benign tumors and assess their po...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25724

    authors: Patterson EE,Holloway AK,Weng J,Fojo T,Kebebew E

    更新日期:2011-04-15 00:00:00

  • Transplantation of human basal cell carcinomas to athymic mice.

    abstract::Basal cell carcinomas (BCCs) obtained from 22 subjects undergoing microscopically controlled surgery were transplanted to 40 athymic (nude) mice. With no further immunosuppression of the mice, no tumor growth was noted in the first 14 attempts. When mice were further immunosuppressed with anti-lymphocyte serum (ALS) i...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850801)56:3<519::aid-cncr28205

    authors: Grimwood RE,Johnson CA,Ferris CF,Mercill DB,Mellette JR,Huff JC

    更新日期:1985-08-01 00:00:00

  • Long-term results of simple and radical nephrectomy for renal cell carcinoma.

    abstract::From 1974 to 1983, simple and radical nephrectomies were performed at the Chaim Sheba Medical Center (Tel Hashomer, Israel) for renal cell carcinoma. The authors reviewed 109 cases that were followed for a period ranging from 5 to 14 years. Simple nephrectomy was performed in 55 patients, and 54 patients underwent rad...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910515)67:10<2506::aid-cncr282

    authors: Ramon J,Goldwasser B,Raviv G,Jonas P,Many M

    更新日期:1991-05-15 00:00:00

  • Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II study.

    abstract:BACKGROUND:Idarubicin, a new anthracycline analogue, is available in an oral preparation, and responses have been observed using relatively aggressive therapy in patients with myelodysplastic syndromes (MDS). The authors studied whether a chronic low-dose schedule would be effective but less myelotoxic. METHODS:Forty-...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19930315)71:6<1989::aid-cncr2820

    authors: Greenberg BR,Reynolds RD,Charron CB,Squillace KM,Lessin LS,Case DC Jr,Gams RA

    更新日期:1993-03-15 00:00:00

  • Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.

    abstract:BACKGROUND:A series of retrospective studies have reported that patients with human epidermal growth factor receptor 2(HER2)-positive breast cancer are at a greater risk of central nervous system (CNS) metastases. Trastuzumab, which does not cross the blood-brain barrier, has been associated with this increased risk. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25771

    authors: Musolino A,Ciccolallo L,Panebianco M,Fontana E,Zanoni D,Bozzetti C,Michiara M,Silini EM,Ardizzoni A

    更新日期:2011-05-01 00:00:00

  • Inhibition of radiogenic mammary carcinoma in rats by estriol or tamoxifen.

    abstract::Mammary carcinomas have been induced by 3.5 Gy whole-body gamma radiation administered at age 40 to 50 days to virgin female Sprague-Dawley rats. In 142 irradiated controls carcinoma incidence averaged 7.8% in survivors observed less than 300 days and 38.3% of those surviving longer (P less than 0.001 by t test). Mamm...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900501)63:9<1685::aid-cncr2820

    authors: Lemon HM,Kumar PF,Peterson C,Rodriguez-Sierra JF,Abbo KM

    更新日期:1989-05-01 00:00:00

  • Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck.

    abstract:BACKGROUND:Patients with basal cell carcinoma (BCC) demonstrate marked variation in clinical phenotype, suggesting the presence of distinct subgroups. Patients with truncal lesions comprise an interesting subgroup, because, although the pathogenesis of these tumors is unclear, there is evidence to suggest that their de...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010715)92:2<354::aid-cncr1330>

    authors: Ramachandran S,Fryer AA,Smith A,Lear J,Bowers B,Jones PW,Strange RC

    更新日期:2001-07-15 00:00:00

  • A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.

    abstract:BACKGROUND:Treatment with traditional cytotoxic chemotherapy regimens containing streptozocin or dacarbazine has resulted in only marginal benefit for patients with metastatic neuroendocrine tumors. The use of these regimens has been further limited by their potential toxicity. Gemcitabine is generally well tolerated a...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/cncr.20466

    authors: Kulke MH,Kim H,Clark JW,Enzinger PC,Lynch TJ,Morgan JA,Vincitore M,Michelini A,Fuchs CS

    更新日期:2004-09-01 00:00:00

  • Radiographic evaluation of metastatic melanoma.

    abstract::Malignant melanoma can potentially involve any organ system in the body once it metastasizes beyond the regional lymph nodes. A survey of the radiographic and associated clinical manifestations of metastatic melanoma is presented. The findings from 74 autopsies of patients who died of metastatic melanoma are included....

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197807)42:1<127::aid-cncr2820420

    authors: Meyer JE

    更新日期:1978-07-01 00:00:00

  • Adjuvant therapy in prostatic cancer.

    abstract:BACKGROUND:Prostatic cancer is an unusual malignancy because, commonly, it is slowly progressive and occurs at an age where the patient's life expectancy is short as a result of considerable competing mortality rates from other diseases. In addition, the place of radical surgery, i.e., radical prostatectomy is still no...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930201)71:3+<992::aid-cncr2820

    authors: Smith PH,Parmar MK

    更新日期:1993-02-01 00:00:00

  • Adjuvant oral alkylating chemotherapy in patients with stage I epithelial ovarian cancer.

    abstract::From November 1973 to May 1986, 50 patients with Stage I epithelial ovarian cancer were treated at the University of Kentucky Medical Center (Lexington, KY) with oral Alkeran (melphalan) chemotherapy after primary surgery. Twenty-two patients had Grade 1 tumors, 23 patients had Grade 2 tumors, and five patients had Gr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890315)63:6<1070::aid-cncr2820

    authors: Gallion HH,van Nagell JR,Donaldson ES,Higgins RV,Powell DE,Kryscio RJ

    更新日期:1989-03-15 00:00:00

  • C-cell disease of the thyroid gland in multiple endocrine neoplasia, type 2b.

    abstract::Multiple endocrine neoplasia, type 2b (MEN 2b) is a disorder characterized by C-cell disease of the thyroid gland (medullary carcinoma or C-cell hyperplasia, or both), pheochromocytoma, ganglioneuromatosis, and skeletal and connective tissue abnormalities. The medullary thyroid carcinoma (MTC) is bilateral and multice...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(197912)44:6<2173::aid-cncr282044

    authors: Carney JA,Sizemore GW,Hayles AV

    更新日期:1979-12-01 00:00:00

  • Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.

    abstract:BACKGROUND:Little is known about cellular level genetic alterations in preinvasive breast lesions, particularly lobular carcinoma in situ. METHODS:We employed fluorescence in situ hybridization (FISH) using pericentromeric (alpha satellite) probes to assess numerical alterations of chromosomes 1, 7, 8, 16, 17, and X i...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(SICI)1097-0142(19960115)77:2<315::AID-CNC

    authors: Visscher DW,Wallis TL,Crissman JD

    更新日期:1996-01-15 00:00:00

  • Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma.

    abstract:BACKGROUND:A National Institutes of Health (NIH) Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma, held in June 1990, recommended breast conservation therapy for the majority of women with Stage I or II breast carcinoma. The authors evaluated the national use of b...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Lazovich D,Solomon CC,Thomas DB,Moe RE,White E

    更新日期:1999-08-15 00:00:00

  • Occurrence of in vitro tetraploidy in the heritable colon cancer syndromes.

    abstract::Increased in vitro tetraploidy occurred in skin cultures derived from all affected patients and some family members at risk studied in families with heritable colon cancer syndromes (15 of 16 Gardner syndrome families, three Oldfield syndrome families, and four families with heritable colon cancer syndrome without pol...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19811001)48:7<1596::aid-cncr2820

    authors: Danes BS

    更新日期:1981-10-01 00:00:00

  • The metabolic syndrome and risk of incident colorectal cancer.

    abstract:BACKGROUND:The authors tested the hypothesis that the metabolic syndrome (> or =3 of the following components: high blood pressure, increased waist circumference, hypertriglyceridemia, low levels of high-density lipoprotein cholesterol, or diabetes/hyperglycemia) is a risk factor for colorectal cancer. METHODS:Data fr...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.21950

    authors: Ahmed RL,Schmitz KH,Anderson KE,Rosamond WD,Folsom AR

    更新日期:2006-07-01 00:00:00